FINNENCE ▪ THE WIRE FILE
THE WIRE · № 74538
News▲ Bullish
11% of U.S. adults now take a GLP-1 for weight loss, roughly 28 million people, up from just 3% in 2024, per Gallup.
KINDNews
DIRECTION▲ Bullish
SOURCES1
ENTITIES4
STORY SIZESTANDALONE
FIRST SEEN
LAST UPDATE
STATEactive
01 THE MACHINE READ
WHY IT MATTERS.
Rapid GLP-1 adoption expands the addressable market for weight-loss drugmakers and pressures food and retail demand.
Adoption tripled since 2024, market still expanding
CATALYST TO WATCH
Next Gallup or prescription data update
MAIN RISK
Supply constraints or pricing pressure cap upside
FULL DISPATCH
11% of U.S. adults now take a GLP-1 for weight loss, roughly 28 million people, up from just 3% in 2024, per Gallup.
02 THE STORY SO FAR
THE RECORD, IN ORDER.
STANDALONE ITEM — NOT YET FOLDED INTO A DEVELOPING STORY.
03 WHO'S INVOLVED
ENTITIES ON FILE.
04 RECEIPTS
THE SOURCE RECORD.
1 SOURCES CONFIRMED05 PROPAGATION
WHAT THIS TOUCHES.
→CORRELATIONshares Consumer
They estimate tariffs added about 2.9 percentage points to consumer goods inflation by February 2026.2026-10-11 02:01 UTC
They estimate tariffs added about 2.9 percentage points to consumer goods inflation by February 2026.2026-10-11 02:01 UTC
←CORRELATIONshares Healthcare
Humana surges after topping 2027 Medicare star ratings2026-10-09 18:15 UTC
Humana surges after topping 2027 Medicare star ratings2026-10-09 18:15 UTC
KEEP READING THE MACHINE
Summaries are generated and may contain errors — every claim links its sources.